Acetylcysteine Sachets – Medical Description

Dosage form: Oral granules sachets (strength varies by manufacturer, commonly 100 mg, 200 mg, or 600 mg per sachet)

Active ingredient:

• Acetylcysteine (N-Acetylcysteine, NAC)

Pharmacologic class: Mucolytic agent.

Description:
Acetylcysteine granules sachets contain N-Acetylcysteine (NAC), a mucolytic medication used to reduce the thickness and viscosity of respiratory mucus, making secretions easier to remove from the airways through coughing. Acetylcysteine acts by breaking disulfide bonds within mucoproteins, decreasing mucus tenacity and facilitating mucus clearance in acute and chronic respiratory conditions associated with excessive mucus production. NAC also exhibits antioxidant activity through replenishment of intracellular glutathione. Acetylcysteine is widely used in respiratory disorders involving thick secretions.

Therapeutic uses:

• Productive cough associated with thick mucus
• Acute bronchitis
• Chronic bronchitis
• Chronic obstructive respiratory diseases with mucus retention
• Respiratory tract conditions with difficult-to-expectorate secretions
• Mucus hypersecretion disorders

Mechanism of action:

Mucolytic activity

• Breaks disulfide linkages within mucus glycoproteins
• Reduces mucus viscosity and elasticity
• Facilitates expectoration and mucus removal

Antioxidant activity

• Serves as a precursor for glutathione, an endogenous antioxidant
• Helps reduce oxidative stress within tissues

Acetylcysteine's mucolytic and antioxidant properties contribute to its therapeutic effects in respiratory disorders.

Possible adverse effects:
Common adverse reactions may include:

• Nausea
• Vomiting
• Diarrhea
• Abdominal discomfort
• Dyspepsia
• Unpleasant sulfur-like taste or odor
• Mouth irritation
• Headache
• Skin rash

Less common adverse effects:

• Bronchospasm (particularly in susceptible individuals)
• Hypersensitivity reactions

Important precautions and warnings:

• Use cautiously in patients with asthma, as bronchospasm may occur.
• Use with caution in patients with a history of peptic ulcer disease.
• Adequate fluid intake may help enhance mucus thinning.
• Concurrent use with cough suppressants (antitussives) may impair mucus clearance by reducing the cough reflex.
• Patients with significant liver or kidney disease should consult healthcare professionals before use.

Patient Disclaimer:
This information is intended for educational purposes only and does not replace physician or pharmacist advice. Patients should use Acetylcysteine granules according to physician recommendations or approved labeling. Medical advice should be sought if symptoms persist, worsen, or occur with fever, breathing difficulty, chest pain, or coughing blood. Patients who are pregnant, breastfeeding, have asthma, peptic ulcer disease, or are taking other medications should consult a healthcare professional before use.

References:

• National Center for Biotechnology Information (NCBI/PMC): Acetylcysteine pharmacology and clinical applications
• Memorial Sloan Kettering Cancer Center: Acetylcysteine patient information
• Cleveland Clinic: Acetylcysteine educational information